Take Control of Your Health: Detect Gastric Cancer Early with DEX-G2

The DEX-G2 Biomarker Blood Test for Early Detection of Gastric Cancer is Coming Soon to U.S. Clinical Settings

Late Stage
Gastric Cancer

0%

Five Year Survival

Gastric cancer, also known as stomach cancer, is the fourth leading cause of cancer deaths worldwide—mainly because it’s often found at a late stage when treatment is less effective and survival rates are low. Traditional testing like endoscopy is invasive, expensive, and not always available to those who need it most. That’s why early detection is so important.

Many people don’t experience symptoms of gastric cancer until the disease is advanced and has spread to other parts of the body. By then, effective treatment options are more limited. The good news is that catching gastric cancer early can dramatically improve outcomes. When found early, the five-year survival rates for gastric cancer range from 70%-90% depending on the stage of the cancer and treatment. But that number drops to less than 30% when the disease is found later. (source: Advances in screening and detection of gastric cancer - PMC)

What Makes DEX-G2 Different?

This innovative, minimally invasive biomarker test detects gastric cancer early—when it’s most treatable—using just a small sample of blood. No scopes. No sedation. Just accurate, reliable answer.

DEX-G2 is a first-of-its kind blood test that looks for tiny molecules, called miRNAs, released by cancer cells in the blood. It uses a dual-technology approach, measuring both:

  • Cell-free miRNAs, which reflect changes in your body

  • Exosomal miRNAs, which are more specific to tumors

This powerful combination gives the DEX-G2 test exceptional accuracy in detecting early-stage gastric cancer. 

SOLUTION

A Better Way to Detect Early Gastric Cancer

  • Finds Early-Stage Disease

    More treatment options are available, and you have a better chance at recovery.

  • Simple Stress-Free Blood Draw

    No scopes, sedation, or invasive procedures.

  • Affordable and Accessible

    Can be ordered by any licensed healthcare provider.

  • Clinically Validated

    Backed by strong scientific data showing sensitivity at 95% for early-stage detection.

  • Confidence and Peace of Mind

    Allows you to be proactive about your health.

While anyone concerned about their risk should talk with their doctor, this test may be especially helpful for people who have one or more risk factors for gastric cancer, including: (Source)

Who Should Consider the DEX-G2 Test?

  • Older age (risk increases after age 50)

  • Family history of gastric cancer

  • Helicobacter pylori (H. pylori) infection

  • Smoking

  • Heavy alcohol use

  • Eating a diet high in smoked, salted, or pickled foods

  • Being of Asian, Hispanic/Latino, or Easter European descent

  • Living in regions or communities with higher rates of gastric cancer (such as South Texas)

If you have concerns or symptoms like persistent indigestion, stomach pain, or unexplained weight loss, speak with your doctor about whether the DEX-G2 test is right for you.

Coming Soon to U.S. Clinical Settings

The DEX-G2 biomarker blood test will soon be available through licensed healthcare providers across the United States. Please check this page often for updates on how and where to get tested.

Take the First Step Toward Early Detection

If you or a loved one is at risk for gastric cancer, talk to your doctor about early detection options. When available, the DEX-G2 blood test offers a simple, stress-free way to get answers—before symptoms begin and when treatment is more effective.

Because early detection is your best, life-saving defense against gastric cancer.